17th International Congress on Myeloproliferative Neoplasms

Event

17th International Congress on Myeloproliferative Neoplasms

presented by 17th International Congress on Myeloproliferative Neoplasms

3 others would like to attend.

Register Now

Notification icon Thursday, November 6, 2025 7:30 AM - Friday, November 7, 2025 4 PM America/New_York

Location Icon New York Marriott at the Brooklyn Bridge 333 Adams Street Brooklyn, NY 11201

Event info

Overview

We are delighted to invite you to attend the 17th International Congress on Myeloproliferative Neoplasms convening on November 6-7, 2025 at the New York Marriott-Brooklyn Bridge in Brooklyn, New York. This event, founded in 2001, and now held annually, serves as a cornerstone for advancing education about the myeloproliferative neoplasms (MPN).

The two-day program features world-renowned faculty and offers CME credits for physicians and CE credits for nurse practitioners, physician assistants, and nurses. With an emphasis on robust faculty interaction and active audience engagement, the MPN Congress features an interactive format with a Q&A session following each speaker’s presentation. In addition, based on positive feedback from the last Congress, we will continue both the debate session and the nurse-led session.

Participants can also enjoy numerous networking opportunities and one-on-one discussions with the faculty and other attendees, promoting collaboration and knowledge-sharing among professionals in the MPN field.

Learning Objectives

Upon completion of this educational activity, learners should be better able to:

1. Explain the pathogenesis, clinical manifestations, and diagnostic approaches for myeloproliferative neoplasms (MPNs).

2. Describe current and emerging therapeutic strategies for MPNs.

3. Discuss the management of disease-related complications in MPN patients. 

4. Recognize the importance of multidisciplinary approach in the management of MPNs. 

Target Audience

This educational activity is intended for hematologists, medical oncologists, translational scientists, and other healthcare professionals (physicians, clinicians, physicians-in-training, oncology nurse practitioners, physician assistants, nurses, etc.) involved and/or interested in the therapeutic management of patients with myeloproliferative neoplasms and related disorders.

Accreditation

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Melton Medical Education, LLC. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

American Academy of CME, Inc. designates this live activity for a maximum of 12.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioners/Nurses:

American Academy of CME, Inc. designates this educational activity for 12.0 ANCC contact hours. Please check onsite for pharmacotherapeutic contact hours available for each session.

PAs:

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 12.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other healthcare professionals will receive a certificate of completion. 

 

For more information, please visit the official event page.

Faculty
  • Richard T. Silver

    Chairman, MPN Congress

  • Jerry L. Spivak

    Chairman and Convener, MPN Congress

3 others would like to attend.

Register Now


Comments 0
Login to view comments. Click here to Login